Emmanuelle Charpentier.
Co-founder of CRISPR-Cas9.
She co-discovered CRISPR-Cas9.
It revolutionised gene editing globally.
In 1968, she was born in France.
In 1995, she completed her PhD in Microbiology at Pierre and Marie Curie University.
In 2012, she co-discovered CRISPR-Cas9.
1. CRISPR-Cas9, a gene-editing tool that cuts and modifies DNA.
2. It offers hope for treating genetic diseases.
3. She co-founded ERS Genomics in 2013.
In 2020, she received the Nobel Prize in Chemistry.
Her research reshaped modern genetics.
She currently leads research at the Max Planck Unit for the Science of Pathogens in Germany.
Want to know more stories?
Visit Emmanuelle Charpentier.